Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
tyrosyl-arginyl-phenylalanyl-lysinamide
Known as:
DALDA
, Tyr-Arg-Phe-Lys-NH2
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (3)
Analgesics
Anti-Arrhythmia Agents
Oligopeptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Session RPE and stress tolerance in young volleyball and basketball players
A. Moreira
,
C. Freitas
,
F. Nakamura
,
M. Aoki
2010
Corpus ID: 220955323
The present study investigated the effect of training load distribution on the perceived sources and symptoms of stress during 6…
Expand
2009
2009
Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.
V. Labroo
,
D. Hebel
,
K. Kirk
,
L. Cohen
,
C. Lemieux
,
P. Schiller
International journal of peptide & protein…
2009
Corpus ID: 595749
In a preliminary communication we reported [(Tetrahedron Lett. 31, 619 (1990)] that acetyl hypofluorite can be used efficiently…
Expand
2004
2004
Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca2+ and K+ channels
D. Keating
,
G. Rychkov
,
M. Adams
,
H. Holgert
,
I. McMillen
,
M. Roberts
Journal of Physiology
2004
Corpus ID: 45554210
Before the preganglionic regulation of the adrenal medulla is established, hypoxia acts directly on the chromaffin cells to evoke…
Expand
2003
2003
Quantification of [Dmt1]DALDA in ovine plasma by on-line liquid chromatography/quadrupole time-of-flight mass spectrometry.
H. Wan
,
D. Desiderio
Rapid Communications in Mass Spectrometry
2003
Corpus ID: 32697455
The synthetic peptide [Dmt(1)]DALDA (Dmt-D-Arg-Phe-Lys-NH(2); Dmt = 2',6'-dimethyltyrosine; 'super-DALDA') is a mu opioid…
Expand
2002
2002
[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
P. Riba
,
Y. Ben
,
T. M. Nguyen
,
S. Fûrst
,
P. Schiller
,
N. Lee
Current Medicinal Chemistry
2002
Corpus ID: 12165392
The clinical effectiveness of morphine is limited by several side effects, including the development of tolerance and dependence…
Expand
2001
2001
Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node
K. Jackson
,
M. Farias
,
A. Stanfill
,
J. Caffrey
Journal of Cardiovascular Pharmacology and…
2001
Corpus ID: 13340096
Background: Methionine-enkephalin-arginine-phenylalanine (MEAP) is an endogenous opiate derived from the C-terminal sequence of…
Expand
2000
2000
A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonists.
A. T. Omoniyi
,
A. Kett
,
D. Wu
,
Y. Soong
,
J. Clapp
,
H. Szeto
Journal of Cardiovascular Pharmacology
2000
Corpus ID: 12288022
We previously reported that i.v. DAMGO (Tyr-D-Ala-Gly-NMePhe-Gly-ol), a selective mu-opioid agonist, causes an increase in blood…
Expand
1999
1999
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress.
Lishmanov YuB
,
L. Maslov
,
N. V. Naryzhnaya
,
S. Tam
Life Science
1999
Corpus ID: 9790107
1995
1995
DALDA (H-Tyr-D-Arg-Phe-Lys-NH2), a potent μ-opioid peptide agonist, affects various patterns of locomotor activities
M. Meyer
,
B. McLaurin
,
M. Meyer
Pharmacology, Biochemistry and Behavior
1995
Corpus ID: 9166872
1995
1995
Tandem mass spectrometry analysis of synthetic opioid peptide analogs.
J. Tseng
,
L. Yan
,
G. Fridland
,
D. Desiderio
Rapid Communications in Mass Spectrometry
1995
Corpus ID: 19401165
Five synthetic opioid peptides that were designed to have specific opioid receptor-binding properties were studied by low energy…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE